Vor Biopharma Inc.
VOR
$16.47
-$0.78-4.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 167.04% | -15.01% | 234.08% | -34.69% | 46.36% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.22% | -50.20% | -66.78% | 7.47% | -0.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 36.65% | -55.38% | 863.64% | -21.84% | 33.33% |
| Total Current Assets | 165.59% | -15.83% | 216.02% | -32.81% | 43.41% |
|
|
|||||
| Total Current Assets | 165.59% | -15.83% | 216.02% | -32.81% | 43.41% |
| Net Property, Plant & Equipment | 4.68% | 13,708.33% | -99.94% | -4.58% | -4.99% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 483.98% | 4.05% | -91.22% | -0.29% | -2.62% |
| Total Assets | 163.35% | -14.19% | 87.88% | -23.50% | 23.19% |
|
|
|||||
| Total Accounts Payable | 479.32% | 32.29% | -82.07% | 147.97% | 14.36% |
| Total Accrued Expenses | 11.65% | -69.53% | 569.02% | -32.63% | 45.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.11% | -- | -- | 1.21% | 1.25% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 33.61% | -67.95% | 251.37% | -10.13% | 29.75% |
|
|
|||||
| Total Current Liabilities | 33.61% | -67.95% | 251.37% | -10.13% | 29.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.10% | -- | -- | -3.98% | -3.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -74.77% | 44.05% | -- | -- | -- |
| Total Liabilities | -73.83% | 40.36% | 3,856.87% | -6.46% | 7.41% |
|
|
|||||
| Common Stock & APIC | 52.02% | 16.67% | 0.34% | 0.34% | 10.91% |
| Retained Earnings | 59.91% | -39.39% | -321.50% | -7.11% | -7.20% |
| Treasury Stock & Other | 241.67% | -14.29% | -39.13% | 4.55% | -67.65% |
| Total Common Equity | 92.62% | -47.80% | -2,378.98% | -31.65% | 32.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 92.62% | -47.80% | -2,378.98% | -31.65% | 32.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 92.62% | -47.80% | -2,378.98% | -31.65% | 32.50% |
|
|
|||||